Reverse Selection for Differential Response to the Locomotor Stimulant Effects of Ethanol Provides Evidence for Pleiotropic Genetic Influence on Locomotor Response to Other Drugs of Abuse

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 10, 2003, Pages 1535-1547

  Bergstrom, Hadley C ^a,b,c   Palmer, Abraham A ^b,c,d   Wood, Robin D ^b,c,e   Burkhart Kasch, Sue ^b,c   McKinnon, Carrie S ^b,c   Phillips, Tamara J ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Columbia University ^*  (United States)

^e Linesberry Research Assoc   (United States)

Author keywords

Locomotor Stimulation; Pleiotropy; Psychomotor Stimulants; Reverse Selection; Selective Breeding

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; COCAINE; METHAMPHETAMINE; MORPHINE; NICOTINE; SCOPOLAMINE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG SENSITIVITY; EUPHORIA; FEMALE; GENETIC SELECTION; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR STIMULATION; RECURRENT SELECTION; REVERSE SELECTION; SELECTIVE BREEDING;

ANIMALS; BREEDING; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; MALE; MICE; MICE, MUTANT STRAINS; MOTOR ACTIVITY; SPECIES SPECIFICITY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

ANIMALIA; EUPHORIA;

EID: 0142135432     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000091226.18969.B9     Document Type: Article

References (59)

1. Andrews CM, Lucki I (2001) Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology 155:221-229.
2. Bassareo V, Tanda G, Petromilli P, Giua C, Di Chiara G (1996) Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacology 124:293-299.
3. Benjamin D, Grant ER, Pohorecky LA (1993) Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res 621:137-140.
4. Berridge CW, Stalnaker TA (2002) Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse 46:140-149.
5. Bishop GB, Cullinan WE, Curran E, Gutstein HB (2002) Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol Dis 10:334-343.
6. Brase DA, Loh HH, Way EL (1977) Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther 201:368-372.
7. Calamandrei G, Ricceri L, Valanzano A (1997) Neonatal cocaine alters behavioural responsiveness to scopolamine and cholinergic development in mice. Pharmacol Biochem Behav 56:557-563.
8. Camarini R, Nogueira Pires ML, Calil HM (2000) Involvement of the opioid system in the development and expression of sensitization to the locomotor-activating effect of ethanol. Int J Neuropsychopharmacol 3:303-309.
9. Castellano C, Filibeck L, Oliverio A (1976) Effects of heroin, alone or in combination with other drugs, on the locomotor activity in two inbred strains of mice. Psychopharmacology 49:29-31.
10. Crabbe JC, Phillips TJ, Kosobud A, Belknap JK (1990) Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin Exp Res 14:141-151.
11. Crabbe JC, Young ER, Deutsch CM, Tam BR, Kosobud A (1987) Mice genetically selected for differences in open-field activity after ethanol. Pharmacol Biochem Behav 27:577-581.
12. Demarest K, McCaughran K Jr, Mahjubi E, Cipp L, Hitzemann R (1999) Identification of an acute ethanol response quantitative trait locus on mouse chromosome 2. J Neurosci 19:549-561.
13. el-Bassel N, Schilling RF, Turnbull JE, Su KH (1993) Correlates of alcohol use among methadone patients. Alcohol Clin Exp Res 17:681-686.
14. El Yacoubi M, Ledent C, Menard JF, Parmentier M, Costentin J, Vaugeois JM (2000) The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br J Pharmacol 129:1465-1473.
15. Falconer DS, Mackay TFC (1996) Introduction to Quantitative Genetics. 4th ed. Longman Group Ltd., Harlow, UK.
16. Ferrari R, Le Novere N, Picciotto MR, Changeux JP, Zoli M (2002) Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur J Neurosci 15:1810-1818.
17. Gamberino WC, Gold MS (1999) Neurobiology of tobacco smoking and other addictive disorders. Psychiatr Clin North Am 22:301-312.
18. Ichikawa J, Chung YC, Li Z, Dai J, Meltzer HY (2002) Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 958:176-184.
19. Kiianmaa K, Hoffman PL, Tabakoff B (1983) Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice. Psychopharmacology 79:291-294.
20. Kozlowski LT, Henningfield JE, Keenan RM, Lei H, Leigh G, Jelinek LC, Haertzen CA (1993) Patterns of alcohol, cigarette, and caffeine use in two drug-abusing populations. J Subst Abuse Treat 10:171-179.
21. Larsson A, Svensson L, Soderpalm B, Engel JA (2002) Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice. Alcohol 28:157-167.
22. Latt NC, Jurd S, Houseman J, Wutzke SE (2002) Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Med J Aust 176:530-534.
23. Luetje CM, Wooten J (1996) Clinical manifestations of transdermal scopolamine addiction. Ear Nose Throat J 75:210-214.
24. McClearn GE, Kakihana R (1981) Selective Breeding for Ethanol Sensitivity: Short-Sleep and Long-Sleep Mice, in Development of Animal Models as Pharmacogenetic Tools (USDHHS-NL4AA Research Monograph No. 6) (McClearn GE, Deitrich RA, Erwin VG eds), pp 147-159. US Department of Health and Human Services, Rockville, MD.
25. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang H, O'Malley SS, Rounsaville BJ (1998) Familial transmission of substance use disorders. Arch Gen Psychiatry 55:973-979.
26. National Institutes of Health (1986) Guidelines for the Care and Use of Laboratory Animals. U.S. Government Printing Office, Washington, DC. (DHEW Publication No. 86-203)
27. O'Malley SS (1995) Integration of opioid antagonists and psychosocial therapy in the treatment of marcotic and alcohol dependence. J Clin Psychiatry 56 (Suppl 7):30-38.
28. Ottomanelli G (1999) Methadone patients and alcohol abuse. J Subst Abuse Treat 16:113-121.
29. Palmer AA, McKinnon CS, Bergstrom HC, Phillips TJ (2002a) Locomotor activity responses to ethanol, other alcohols, and GABA-A acting compounds in forward- and reverse-selected FAST and SLOW mouse lines. Behav Neurosci 116:958-967.
30. Palmer AA, Miller MN, McKinnon CS, Phillips TJ (2002b) Sensitivity to the locomotor stimulant effects of ethanol and allopregnanolone is influenced by common genes. Behav Neurosci 116:126-137.
31. Palmer AA, Phillips TJ (2002) Effect of forward and reverse selection for ethanol-induced locomotor response on other measures of ethanol sensitivity. Alcohol Clin Exp Res 26:1322-1329.
32. Phillips TJ, Burkhart-Kasch S, Gwiazdon C, Crabbe JC (1992) Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity. J Pharmacol Exp Ther 261:525-533.
33. Phillips TJ, Burkhart-Kasch S, Terdal ES, Crabbe JC (1991) Response to selection for ethanol-induced locomotor activation: genetic analyses and selection response characterization. Psychopharmacology 103:557-566.
34. Phillips TJ, Dickinson S, Burkhart-Kasch S (1994) Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 108:789-803.
35. Phillips TJ, Huson M, Gwiazdon C, Burkhart-Kasch S, Shen EH (1995) Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice. Alcohol Clin Exp Res 19:269-278.
36. Phillips TJ, Huson M, McKinnon CL (1998) Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice. J Neurosci 18:3023-3034.
37. Phillips TJ, Shen EH (1996) Neurochemical bases of locomotion and ethanol stimulant effects, in International Review of Neurobiology (Bradley RJ, Harris RA, Jenner P eds), Vol. 39, pp 243-282. Academic Press, San Diego.
38. Phillips TJ, Shen EH, McKinnon CS, Burkhart-Kasch S, Lessov CN, Palmer AA (2002) Forward, relaxed and reverse selection for reduced and enhanced sensitivity to ethanol's locomotor stimulant effects in mice. Alcohol Clin Exp Res 26:593-602.
39. Pohorecky LA (1977) Biphasic action of ethanol. Biobehav Rev 1:231-240.
40. Pulvirenti L, Maldonado-Lopez R, Koob GF (1992) NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res 594:327-330.
41. Pulvirenti L, Swerdlow NR, Koob GF (1991) Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol Biochem Behav 40:841-845.
42. Rittmannsberger H, Silberbauer C, Lehner R, Ruschak M (2000) Alcohol consumption during methadone maintenance treatment. Eur Addict Res 6:2-7.
43. Rosenzweig-Lipson S, Thomas S, Barrett JE (1997) Attenuation of the locomotor activating effects of d-amphetamine, cocaine, and scopolamine by potassium channel modulators. Prog Neuropsychopharmacol Biol Psychiatry 21:853-872.
44. Rouge-Pont F, Usiello A, Benoit-Marand M, Gonon F, Piazza PV, Borrelli E (2002) Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci 22:3293-3301.
45. Segal DS, Kuczenski R (1999) Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses. Psychopharmacology 142:182-192.
46. Shen EH, Crabbe JC, Phillips TJ (1995a) Dopamine antagonist effects on the locomotor activity of naive and ethanol-treated FAST and SLOW selected lines of mice. Psychopharmacology 118:28-36.
47. Shen EH, Dorow JD, Huson M, Phillips TJ (1996) Correlated responses to selection in FAST and SLOW mice: effects of ethanol on ataxia, temperature, sedation, and withdrawal. Alcohol Clin Exp Res 20:688-696.
48. Shen EH, Harland RD, Crabbe JC, Phillips TJ (1995b) Bidirectional selective breeding for ethanol effects on locomotor activity: characterization of FAST and SLOW mice through selection generation 35. Alcohol Clin Exp Res 19:1234-1245.
49. Shiffman S, Balabanis M (1995) Associations between alcohol and tobacco, in Alcohol and Tobacco: From Basic Science to Clinical Practice (NIAAA Research Monograph No. 30) (Fertig JB, Allen JP eds), pp 17-36. U.S. Department of Health and Human Services, Washington, DC (NIH Publication No. 95-3931).
50. Smolen A, Marks MJ, DeFries JC, Henderson ND (1994) Individual differences in sensitivity to nicotine in mice: response to six generations of selective breeding. Pharmacol Biochem Behav 49:531-540.
51. Söderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA (2000) Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113:85-96.
52. Solinas M, Ferre S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22:6321-6324.
53. Swerdlow NR, Koob GF (1985) Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat. Pharmacol Biochem Behav 23:303-307.
54. Tizabi Y, Copeland RL Jr, Louis VA, Taylor RE (2002) Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res 26:394-399.
55. True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC, Eisen SA, Lyons MJ, Goldberg J, Tsuang M (1999) Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56:655-661.
56. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.
57. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP (1997) Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry 54:737-742.
58. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
59. Zhang Y, Schlussman SD, Ho A, Kreek MJ (2001) Effect of acute binge cocaine on levels of extracellular dopamine in the caudate putamen and nucleus accumbens in male C57BL/6J and 129/J mice. Brain Res 923:172-177.